2024
DOI: 10.3390/pharmaceutics16121527
|View full text |Cite
|
Sign up to set email alerts
|

Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives

Umme Hani,
Vikram T. Choudhary,
Mohammed Ghazwani
et al.

Abstract: Cancer, the most common condition worldwide, ranks second in terms of the number of human deaths, surpassing cardiovascular diseases. Uncontrolled cell multiplication and resistance to cell death are the traditional features of cancer. The myriad of treatment options include surgery, chemotherapy, radiotherapy, and immunotherapy to treat this disease. Conventional chemotherapy drug delivery suffers from issues such as the risk of damage to benign cells, which can cause toxicity, and a few tumor cells withstand… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 207 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?